Global Medical Radioactive Microsphere Injection Market Growth 2025-2031

The global Medical Radioactive Microsphere Injection market size is predicted to grow from US$ 110 million in 2025 to US$ 175 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Medical Radioactive Microsphere Injection is a radioactive therapeutic drug that uses vascular intervention to deliver microspheres (usually with a particle size of microns) loaded with radionuclides (such as yttrium [90Y], etc.) directly to the tumor blood supply artery or lesion site. This drug uses the difference in blood supply distribution between tumor tissue and normal tissue to selectively aggregate microspheres at the tumor site, and kills tumor cells at close range through the beta rays released by the decay of radionuclides in the microspheres, while reducing damage to surrounding normal tissues. It has the dual effects of internal radiotherapy and embolization, which can significantly improve the local control rate of tumors and prolong patient survival. It is suitable for the treatment of solid tumors such as primary liver cancer that cannot be surgically removed and liver metastasis of colorectal cancer.

United States market for Medical Radioactive Microsphere Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Medical Radioactive Microsphere Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Medical Radioactive Microsphere Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Medical Radioactive Microsphere Injection players cover New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Medical Radioactive Microsphere Injection Industry Forecast” looks at past sales and reviews total world Medical Radioactive Microsphere Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Radioactive Microsphere Injection sales for 2025 through 2031. With Medical Radioactive Microsphere Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Radioactive Microsphere Injection industry.

This Insight Report provides a comprehensive analysis of the global Medical Radioactive Microsphere Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Radioactive Microsphere Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Radioactive Microsphere Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Radioactive Microsphere Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Radioactive Microsphere Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Medical Radioactive Microsphere Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Holmium 166 Microsphere Injection
Yttrium 90 Microsphere Injection
Others

Segmentation by Application:
Cancer Treatment
Diagnosis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
New Radiomedicine Technology
Grand Pharmaceutical Group Limited
YH Nu-Med
Boston Scientific
Sirtex Medical Limited
Terumo
ABK Biomedical
AtomVie
BWXT Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Radioactive Microsphere Injection market?

What factors are driving Medical Radioactive Microsphere Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Radioactive Microsphere Injection market opportunities vary by end market size?

How does Medical Radioactive Microsphere Injection break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more